Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
4.610
+0.240 (5.49%)
At close: May 20, 2025, 4:00 PM
4.580
-0.030 (-0.65%)
After-hours: May 20, 2025, 7:03 PM EDT
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $410.95 million as of May 20, 2025. Its market cap has decreased by -20.38% in one year.
Market Cap
410.95M
Enterprise Value
-17.49M
1-Year Change
-20.38%
Ranking
Category
Stock Price
$4.61
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $410.95M, a decrease of -52.73%. That is a compound annual growth rate of -17.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 389.56M | -18.42% |
| Dec 31, 2024 | 477.50M | -57.41% |
| Dec 29, 2023 | 1.12B | -5.95% |
| Dec 30, 2022 | 1.19B | -32.88% |
| Dec 31, 2021 | 1.78B | 104.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |